Unique immune cell linked to aggressive leukemia may lead to improved treatment outcomes

A new study by Indiana University School of Medicine researchers has revealed a breakthrough in the fight against acute myeloid leukemia, one of the most aggressive and fatal blood cancers in adults. The discovery of a previously unrecognized immune cell could lead to new therapies that are less treatment-resistant than current options for patients—meaning higher survival rates for people with blood cancers.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup